Neurology · Medical Literature
Effect of High-Power Laser Therapy on Myoelectrical Activities of Suboccipital Muscles and Quality of Life in Patients with Cervicogenic Headache.
Abstract
Cervicogenic headache (CGH) is a secondary disorder caused by cervical musculoskeletal dysfunction in the cervical vertebrae, with involvement of the upper three cervical segments. The pain initiates in the neck and is often intensified by head or neck movements. This condition imposes a considerable socioeconomic burden, affecting both community well-being and public health systems. To explore how high-power laser therapy influences pain intensity, suboccipital muscle activity, functional disability, and quality of life (QoL) in patients with CGH. A randomized controlled trial was conducted on 40 participants (both males and females) diagnosed with CGH for a duration of at least 6 months, experiencing unilateral neck pain radiating to the suboccipital region. Participants were randomly allocated into two equal groups. The study group (A) received high-power Laser therapy in addition to a conventional physical therapy program, while the control group (B) received a placebo laser alongside the same conventional physical therapy program. Both groups received 3 times per week for 6 weeks, with each session lasting approximately 45-60 min. Outcome measures included the visual analog scale for pain intensity measurement, electromyography (EMG) to assess suboccipital muscle myoelectric activity, the Headache Impact Test-6 questionnaire to assess participants' functional health and well-being, the Neck Disability Index to assess functional impairment, and the 36-Item Short Form Health Survey to evaluate QoL. Assessments were performed before and after the intervention (6 weeks). Group A showed statistically significant improvements in pain intensity, EMG parameters, functional disability, headache impact, and QoL compared with Group B. High-power laser therapy, when used alongside conventional physiotherapy, may be an effective approach for reducing symptoms and improving functional outcomes in patients with CGH.
Clinical relevance
Cervicogenic headache (CGH) is a secondary headache disorder arising from upper cervical musculoskeletal dysfunction (C1–C3) that imposes significant socioeconomic burden on both patients and public health systems, yet optimal adjunctive physical therapy modalities remain incompletely defined. This randomized controlled trial addresses the clinical gap regarding the efficacy of high-power laser therapy (HPLT) on objective neuromuscular outcomes—specifically suboccipital EMG activity—alongside patient-reported outcomes in a CGH population. Given the chronicity of CGH (≥6 months inclusion criterion) and its resistance to conventional monotherapy, these findings are timely and directly relevant to neurologists and physical medicine specialists managing refractory cervicogenic pain.
Key findings
1. Study group (A; HPLT + conventional physiotherapy) demonstrated statistically significant reductions in pain intensity on the Visual Analog Scale (VAS) compared with the placebo laser control group (B) after 6 weeks, though precise mean differences, effect sizes, and p-values were not reported in the abstract. 2. EMG assessment of suboccipital muscle myoelectrical activity showed statistically significant improvements in Group A versus Group B, providing objective neuromuscular evidence of HPLT's effect beyond subjective pain reporting; specific EMG amplitude or frequency values were not enumerated in the abstract. 3. Functional disability as measured by the Neck Disability Index (NDI) was significantly reduced in Group A compared with Group B following the 6-week intervention; quantitative between-group differences and confidence intervals were not provided in the abstract. 4. Headache impact, assessed via the Headache Impact Test-6 (HIT-6), showed statistically significant improvement in Group A over Group B, indicating reduced burden on functional health and well-being; exact score changes were not specified in the abstract. 5. Quality of life evaluated by the 36-Item Short Form Health Survey (SF-36) was significantly improved in Group A compared with Group B after 6 weeks; domain-level breakdowns and effect sizes were not reported in the abstract. 6. The intervention protocol consisted of HPLT administered 3 sessions per week for 6 weeks (~45–60 min/session) in a sample of 40 participants (n=20 per group, mixed sex) with confirmed unilateral CGH of ≥6 months' duration; no adverse events were mentioned in the abstract.
Practice implications
Clinicians managing chronic CGH (≥6 months, unilateral neck pain with suboccipital radiation) may consider integrating high-power laser therapy as an adjunct to conventional physiotherapy programs, delivered at a frequency of 3 sessions per week over 6 weeks, to achieve superior reductions in pain, headache impact, and functional disability compared with physiotherapy alone. Patient selection should prioritize those with confirmed cervical musculoskeletal involvement of the upper three cervical segments (C1–C3), and objective EMG monitoring of suboccipital muscles may serve as a useful tool to track neuromuscular treatment response. However, given the small sample size (n=40), absence of reported effect sizes and confidence intervals in the abstract, and single-center design, replication in larger multicenter trials with longer follow-up is necessary before broad incorporation into CGH management guidelines.